ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,067.00
-1.24%
S&P ASX All Technology
3,766.30
-0.74%
Brent Oil
72.72
0.00%
US Dollar vs AUD
1.59949
0.00%
Bitcoin
96,944.94
-0.27%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Poolbeg Pharma Plc (POLB) Share Price

Poolbeg Pharma Plc

Poolbeg Pharma Plc (POLB)

LSE
7.15
-0.05
(-0.69%)
Closed 23 December 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
7.15
Bid
7.00
Offer
7.30
Volume
164,233
7.15 Day's Range 7.20
7.05 52 Week Range 15.70
Market Cap
35.75M
Previous Close
7.20
Open
7.20
Last Trade
6203
@
7.018
(O)
Last Trade Time
Financial Volume
11,661p
VWAP
7.10
Average Volume (3m)
1,100,675
Shares Outstanding
500,000,000
Dividend Yield
-
PE Ratio
-9.05
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-3.93M

About Poolbeg Pharma Plc

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.poolbegpharma.com
Headquarters
London, Gbr
Founded
-
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 7.20p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 7.05p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £36 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -9.05.

Ask ADVFN Intelligence (AI)

POLB Latest News

More News

Poolbeg Pharma PLC Poolbeg presents POLB 001 data at 66th ASH Meeting

Poolbeg Pharma PLC 09 December 2024   REACH                                                                               Poolbeg Pharma plc presents POLB 001 pre-clinical study data at the...

09 December 2024
RNS Non-Regulatory

Poolbeg Pharma granted US patent for influenza treatment

Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. The London-based ...

21 November 2024
Alliance News

Poolbeg Pharma PLC POLB 001 Patent Granted in United States

Poolbeg Pharma PLC 20 November 2024   Poolbeg Pharma plc - POLB 001 Patent Granted in United States   Further strengthens Poolbeg's robust intellectual property portfolio   20 November...

20 November 2024
RNS Regulatory News

Poolbeg Pharma PLC POLB 001 data to be presented at ASH

Poolbeg Pharma PLC 06 November 2024   REACH                                                                               Poolbeg Pharma plc to present POLB 001 pre-clinical study data at the...

06 November 2024
RNS Non-Regulatory

Poolbeg Pharma PLC Interim results for the six months to 30 June 2024

Poolbeg Pharma PLC 18 September 2024                                                                                 Poolbeg Pharma plc - Interim results for the six months to 30 June 2024  ...

18 September 2024
RNS Regulatory News

Poolbeg Pharma PLC H.C. Wainwright Global Investment Conference

Poolbeg Pharma PLC 27 August 2024   Poolbeg Pharma plc   Poolbeg Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference   27 August 2024 - Poolbeg Pharma (AIM: POLB...

27 August 2024
RNS Non-Regulatory

Poolbeg Pharma PLC Holding(s) in Company

Poolbeg Pharma PLC 12 August 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

12 August 2024
RNS Regulatory News

EARNINGS AND TRADING: Man Group profit rises; Petershill AUM increases

The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not sepa ...

27 July 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2-2.721088435377.357.47.154215787.23315226DE
4-0.55-7.142857142867.77.757.057636667.29292486DE
12-2.45-25.52083333339.69.67.0511006757.95392776DE
26-5.6-43.921568627512.7513.97.05120153710.45636349DE
52-2.05-22.28260869579.215.77.05157856410.6924981DE
156-2.35-24.73684210539.515.74.113335858.76531437DE
260-3.85-351115.74.113119398.97599984DE

POLB - Frequently Asked Questions (FAQ)

What is the current Poolbeg Pharma share price?
The current share price of Poolbeg Pharma is 7.15p
How many Poolbeg Pharma shares are in issue?
Poolbeg Pharma has 500,000,000 shares in issue
What is the market cap of Poolbeg Pharma?
The market capitalisation of Poolbeg Pharma is GBP 36M
What is the 1 year trading range for Poolbeg Pharma share price?
Poolbeg Pharma has traded in the range of 7.05p to 15.70p during the past year
What is the PE ratio of Poolbeg Pharma?
The price to earnings ratio of Poolbeg Pharma is -9.05
What is the reporting currency for Poolbeg Pharma?
Poolbeg Pharma reports financial results in GBP
What is the latest annual profit for Poolbeg Pharma?
The latest annual profit of Poolbeg Pharma is GBP -3.93M
What is the registered address of Poolbeg Pharma?
The registered address for Poolbeg Pharma is 40 BANK STREET, FLOOR 24, LONDON, E14 5NR
What is the Poolbeg Pharma website address?
The website address for Poolbeg Pharma is www.poolbegpharma.com
Which industry sector does Poolbeg Pharma operate in?
Poolbeg Pharma operates in the COML PHYSICAL, BIOLOGCL RESH sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TIRTiger Royalties And Investments Plc
0.15p
(50.00%)
3.41M
BAYBay Capital Plc
5.50p
(19.57%)
209.68k
MASTMast Energy Developments Plc
0.19p
(18.75%)
20.09M
MHNMenhaden Resource Efficiency Plc
148.50p
(18.33%)
1M
ZENZenith Energy Ltd.
2.50p
(16.28%)
3.93M
TRYBTribe Technology Plc
0.115p
(-79.09%)
24.27M
NMTNeometals Ltd
2.75p
(-35.29%)
49.4k
SNGSynairgen Plc
2.46p
(-34.31%)
4.31M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M
AYMAnglesey Mining Plc
0.70p
(-17.65%)
2.99M
NTVONativo Resources Plc
0.002p
(5.26%)
971.94M
TRPTower Resources Plc
0.035p
(9.38%)
620.03M
LLOYLloyds Banking Group Plc
54.16p
(-0.26%)
341.48M
ORCPOracle Power Plc
0.0255p
(-1.92%)
192.93M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M

Discussion

View Full Feed
elks elks 10 minutes ago
Loading more pre market.
TNXP
elks elks 10 minutes ago
Loading more very bullish now. That offering is done closed. Should zooooom right back to dollar land.
TNXP
glenn1919 glenn1919 12 minutes ago
VUZI.....BLIN.....TNXP......LAES......VVOS......https://stockcharts.com/h-sc/ui?s=VUZI&p=W&yr=1&mn=3&dy=0&id=p96837884856
BLIN LAES TNXP
Dingbatt Dingbatt 12 minutes ago
Jay tee
I expect the government to pay RNVA big time for giving them a covad enima since they just gave out 4.6 billion to pay for high level education and sell off border wall material so they can sell drugs without prescriptions
RNVA
learningcurve2020 learningcurve2020 13 minutes ago
Moffit's vaccine is specifically pulsed to target HER2,3,4.  What stood out to me was this vaccine is being used without chemorad.  

"We are seeing breast tumors disappear in th
NWBO
Robert31 Robert31 14 minutes ago
What is the customers see the supplier as too small
ChatGPT said:
ChatGPT
If customers perceive your company as "too small," it can be a barrier to sales, as they may feel your business lacks the resources, reliability, or scale of larger suppliers. To address this perception, h
SEV
StayHumble StayHumble 14 minutes ago
💹$95 MOASS Possible💹Per SEC SHORT Regs, Right idiot?
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
DBMM
Robert31 Robert31 15 minutes ago
Chat: How do you fix a Sales order problem, when you product is superior but customers are not ordering from you?
ChatGPT said:
ChatGPT
When your product is superior but customers aren't ordering from you, it often indicates a gap between your product's quality and the way custo
CRM PPC
hedge_fun hedge_fun 15 minutes ago
At last report, SFRX was the only entity……

with permits and no right to title.

Very few have permits

Permits are useless without right to title and real salvors know that. For some reason, SFRX’s BOD thinks permits without right to title are a good pursu
SFRX
BullNBear52 BullNBear52 16 minutes ago
I was discussing Rizzo who only played in 92 games last year due to injuries.
silkcash silkcash 21 minutes ago
A-dude wow! Merry Xma$
KBLB
RKhan2011 RKhan2011 23 minutes ago
Goood Morning to all fella $HESGers. I tink 2025 will bring a good chinease buyer to buy $HESG OINK OINK 🐷 to da moooooon.
HESG HESGERS
glenn1919 glenn1919 24 minutes ago
RGTI.....KULR......MYNZ.......AEMD.........................https://stockcharts.com/h-sc/ui?s=RGTO&p=W&yr=1&mn=3&dy=0&id=p96837884856
AEMD KULR MYNZ
patrique4 patrique4 25 minutes ago
AABB will go nuts soon, very soon.. better load up @bottom
AABB
JOoa0ky JOoa0ky 25 minutes ago
Maybe 3 fiddy by June 2025.
FNMA
titan11 titan11 25 minutes ago
Thanks! I think....
CaptBeer CaptBeer 26 minutes ago
Good Sunday morning my $AMRN Friends! I was looking over the Italian (AIFA) VAZKEPA® inclusion criteria for reimbursement and one of the criterion was a BMI >= 27 mg/m^2. This is the first ever criteria outside the REDUCE-IT label, and it seemed overly restrictive to me.

Then It dawn
AMRN
Large Green Large Green 26 minutes ago
Fred, it is cold here this morning around 43 degrees near the pier in Naples. Did you bring this nasty weather?

Hopefully, you can do better with our distributions. I predict between $9.00 and $15.00 on or before February 20, 2025.



…
learningcurve2020 learningcurve2020 26 minutes ago
Your dot connecting is all well and good but you ignored my message, as usual.  Moffit's DC product is more like Direct than L, first of all.  Moffits vaccine appears highly effective but yet LP allowed Direct to collect dust for a decade. She's lost a considerable head start and likely the patent p
NWBO
Tadaaa Tadaaa 28 minutes ago
A New Chapter for The HBAR Foundation

https://www.hbarfoundation.org/blog-post/a-new-chapter-for-the-hbar-foundation
HBARUSD
glenn1919 glenn1919 29 minutes ago
VRAR....LAES.......VUZI........FRSX........PSNL.........................https://stockcharts.com/h-sc/ui?s=FRSX&p=W&yr=1&mn=3&dy=0&id=p96837884856
FRSX LAES PSNL
urge2surge urge2surge 30 minutes ago
Bottom reveal on weekly. Stellar obv and MACD about to turn. Zero dillutions. Nice set up for extensive upside run.

https://stockcharts.com/sc3/ui/?s=SMCE

https://www.otcmarkets.com/stock/SMCE/security
SMCE
powerwalker powerwalker 30 minutes ago
Best of luck, Roger … it is time for a Christmas present for you and your elbow Virginians.

Merry Christmas and a prosperous 2025.
powerwalker
VRNA
HoldHigh HoldHigh 30 minutes ago
If you have the time, this is a pretty good podcast. At least gives some insight on the issue. https://www.marijuanamoment.net/trump-ally-who-lobbies-for-marijuana-industry-predicts-rescheduling-and-banking-will-get-done-under-new-administration-but-not-legalization/
TCNNF
Robert31 Robert31 30 minutes ago
Shifting strategy as suggested by Chat, just shifts the problem it does not change the problem. Their partners need to win orders. They are not winning orders. Why? - Omar needs to fix that. They already have the better chip..... why no orders? FIX THAT
SEV

Your Recent History

LSE
POLB
Poolbeg Pharma
LSE
76KD
Municplty 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads